Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia.
Jiménez-Vicente C, Arribas I, Pomares H, Ramil G, Castaño-Diez S, Pérez-Valencia AI, Sturla AL, López-Guerra M, Martinez-Roca A, Zugasti I, Guijarro F, Cortés-Bullich A, Merchán B, Triguero A, Monge I, Tuca A, Oñate G, Garrido A, Sierra J, Arnan M, Esteve J, Díaz-Beyá M; Spanish CETLAM Group. Jiménez-Vicente C, et al. Among authors: merchan b. Haematologica. 2025 Jan 23. doi: 10.3324/haematol.2024.286589. Online ahead of print. Haematologica. 2025. PMID: 39844754 Free article.
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens.
Martínez-Roca A, Jiménez-Vicente C, Merchán B, Castaño-Diez S, Zugasti I, Brillembourg H, Bataller Á, Guijarro F, Cortés-Bullich A, Trigueros A, Pérez-Valencia AI, Gallego C, Ballestar N, Rodríguez-Lobato LG, Carcelero E, Díaz-Beyá M, Esteve J, Fernández-Avilés F. Martínez-Roca A, et al. Among authors: merchan b. Cancers (Basel). 2024 Dec 23;16(24):4274. doi: 10.3390/cancers16244274. Cancers (Basel). 2024. PMID: 39766173 Free PMC article.
Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study.
Jiménez-Vicente C, Guardia-Torrelles A, Pérez-Valencia AI, Martínez-Roca A, Castaño-Diez S, Guijarro F, Cortés-Bullich A, Merchán B, Triguero A, Hernández I, Brillembourg H, Munárriz D, Zugasti I, Fernández-Avilés F, Diaz-Beyá M, Esteve J. Jiménez-Vicente C, et al. Among authors: merchan b. Ann Hematol. 2024 Oct;103(10):4033-4043. doi: 10.1007/s00277-024-05923-5. Epub 2024 Aug 29. Ann Hematol. 2024. PMID: 39207559 Free PMC article.
Allogeneic hematopoietic cell transplantation with sequential conditioning regimen in relapsed refractory acute myeloid leukemia.
Tolosa-Ridao C, Suárez-Lledó M, Jiménez-Vicente C, Cortés-Bullich A, Merchan B, Martínez-Roca A, Guijarro F, Castaño-Díez S, Rosiñol L, Fernández-Avilés F, Martínez C, Díaz-Beya M, Esteve J, Rovira M, Salas MQ. Tolosa-Ridao C, et al. Among authors: merchan b. Bone Marrow Transplant. 2024 Aug;59(8):1199-1201. doi: 10.1038/s41409-024-02310-6. Epub 2024 May 22. Bone Marrow Transplant. 2024. PMID: 38778147 No abstract available.
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.
Caballero JC, Dávila J, López-Pavía M, Such E, Bernal T, Ramos F, Calabuig M, Hernández Sánchez JM, Pomares H, Sánchez Barba M, Abáigar M, González B, Merchán B, Sancho-Tello R, Callejas M, Muñoz-Novas C, Cerveró C, Sanz G, Hernández Rivas JM, Díez Campelo M. Caballero JC, et al. Among authors: merchan b. Ther Adv Hematol. 2024 Jan 4;15:20406207231218157. doi: 10.1177/20406207231218157. eCollection 2024. Ther Adv Hematol. 2024. PMID: 38186638 Free PMC article.
Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain.
de la Rubia J, Alonso R, Clavero ME, Askari E, García A, Antón C, Fernández M, Escalante F, García A, Rios-Tamayo R, Conesa V, Bermúdez MA, Merchán B, Velasco AE, Blanchard MJ, Sampol A, Gainza E, Hernández PM, Alegre A. de la Rubia J, et al. Among authors: merchan b. Cancers (Basel). 2023 May 29;15(11):2964. doi: 10.3390/cancers15112964. Cancers (Basel). 2023. PMID: 37296925 Free PMC article.
Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA.
Garcia-Gisbert N, Garcia-Ávila S, Merchán B, Salido M, Fernández-Rodríguez C, Gibert J, Fernández-Ibarrondo L, Camacho L, Lafuente M, Longarón R, Espinet B, Vélez P, Pujol RM, Andrade-Campos M, Arenillas L, Salar A, Calvo X, Besses C, Bellosillo B. Garcia-Gisbert N, et al. Among authors: merchan b. Blood Adv. 2022 May 24;6(10):3178-3188. doi: 10.1182/bloodadvances.2021006565. Blood Adv. 2022. PMID: 35192693 Free PMC article.
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.
Bataller A, Garrido A, Guijarro F, Oñate G, Diaz-Beyá M, Arnan M, Tormo M, Vives S, de Llano MPQ, Coll R, Gallardo D, Vall-Llovera F, Escoda L, Garcia-Guiñon A, Salamero O, Sampol A, Merchan BM, Bargay J, Castaño-Díez S, Esteban D, Oliver-Caldés A, Rivero A, Mozas P, López-Guerra M, Pratcorona M, Zamora L, Costa D, Rozman M, Nomdedéu JF, Colomer D, Brunet S, Sierra J, Esteve J. Bataller A, et al. Among authors: merchan bm. Blood Adv. 2022 Feb 22;6(4):1193-1206. doi: 10.1182/bloodadvances.2021005585. Blood Adv. 2022. PMID: 34911079 Free PMC article.
20 results